Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT00064285
First received: July 8, 2003
Last updated: April 30, 2010
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given